—
Price
—
Market Cap
—
P/E Ratio
—
Forward P/E
—
EPS (TTM)
—
Dividend Yield
—
Cash
—
Total Debt
—
Shares Out
Institutional Ownership of Bio-rad Laboratories-a
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| No funds currently hold this stock. | |||||
Trading Activity for Bio-rad Laboratories-a
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| 2026-Q2 | |||||
| SELL | EXIT | — | — | — | |
| 2026-Q1 | |||||
| SELL | -28.5% | 162.8K | $45M | — | |
| 2025-Q4 | |||||
| SELL | -4.1% | 227.6K | $69M | — | |
| 2025-Q3 | |||||
| SELL | -24.8% | 237.3K | $67M | — | |
| 2025-Q2 | |||||
| SELL | -2.6% | 315.3K | $76M | — | |
| 2025-Q1 | |||||
| BUY | +5.0% | 323.8K | $79M | — | |
| 2024-Q4 | |||||
| SELL | -3.1% | 308.5K | $101M | — | |
| 2024-Q3 | |||||
| SELL | -2.0% | 318.3K | $107M | — | |
| 2024-Q2 | |||||
| SELL | -5.5% | 325.0K | $89M | — | |
| 2024-Q1 | |||||
| SELL | -5.5% | 344.0K | $119M | — | |
| 2023-Q4 | |||||
| BUY | +11.6% | 364.1K | $118M | — | |
| 2023-Q3 | |||||
| BUY | +0.2% | 326.1K | $117M | — | |
| 2023-Q2 | |||||
| BUY | NEW | 325.5K | $123M | — | |
Insider Trading for Bio-rad Laboratories-a
No Insider Transactions
No Form 4 filings found for this stock in the last 2 years.